HSE pays 47% more for 'brand name' drugs

A new survey has found that Ireland's Health Service is paying one-and-a-half times more than Britain for brand name medicines.

The study carried out for the Swedish pharmaceutical sector shows that Ireland pays more than any other Northern European country for drugs that are still under patent.

The survey found that the HSE pays 47% more than Britain's NHS for such "brand name" drugs.

More in this Section

'God above is in charge of the weather and we can't do anything about it'

No winner of Lotto jackpot

Gardaí look for help to find missing girl Chloe Elderfield

Government takes in €475m more than expected in year's first quarter


You might also like

Today's Stories

Abuse victim stands over allegations against ex-garda

Firefighter made hoax calls to feel ‘sense of excitement’

Three development packages worth €30m hit the Cork market

Boyfriend told woman lick beans off floor

Lifestyle

The host with the most...Graham Norton has a busy schedule with the Baftas and Eurovision on his cards

Nicci Taylor is looking for life and love on the road

Should couples ask for cash as a wedding present?

Make sure your dream home doesn't become a nightmare

More From The Irish Examiner